| Predicted Trait | |
| Reported Trait | Melanomas of skin (diagnosis or history) | 
| Mapped Trait(s) | melanoma (EFO_0000756) | 
| Additional Trait Information | PheCode 172.1 | 
| Score Construction | |
| PGS Name | PRSWEB_PHECODE172.1_GWAS-Catalog-r2019-05-03-X172.1_P_5e-08_MGI_20200608 | 
| Development Method | |
| Name | GWAS Hits | 
| Parameters | LD Clumping (MAF >= 1%, r^2 <= 0.1) & P<=5e-08 | 
| Variants | |
| Original Genome Build | GRCh37 | 
| Number of Variants | 18 | 
| Effect Weight Type | NR | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000118 | 
| Citation (link to publication) | Fritsche LG et al. Am J Hum Genet (2020) | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
GWAS Catalog: GCST000198 Europe PMC: 18488026  | 
                        
                            1,728 individuals | European | NR | 
GWAS Catalog: GCST000437 Europe PMC: 19578364  | 
                        
                            5,456 individuals | European | NR | 
GWAS Catalog: GCST001266 Europe PMC: 21983785  | 
                        
                            6,555 individuals | European | NR | 
GWAS Catalog: GCST001267 Europe PMC: 21983787  | 
                        
                            10,422 individuals | European | NR | 
GWAS Catalog: GCST001886 Europe PMC: 23455637  | 
                        
                            4,919 individuals | European | NR | 
GWAS Catalog: GCST004142 Europe PMC: 28212542  | 
                        
                            291,407 individuals | European | NR | 
GWAS Catalog: GCST003061 Europe PMC: 26237428  | 
                        
                            36,077 individuals | European | NR | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
Europe PMC: 32991828  | 
                        
                            [ 
  | 
                        
                            European | MGI | PheCode:172.1; ICD9CM:172.0, 172.1, 172.2, 172.3, 172.4, 172.5, 172.6, 172.7, 172.8, 172.9, V10.82; ICD10CM:C43, C43.0, C43.1, C43.10, C43.11, C43.12, C43.2, C43.20, C43.21, C43.22, C43.3, C43.30, C43.31, C43.39, C43.4, C43.5, C43.51, C43.52, C43.59, C43.6, C43.60, C43.61, C43.62, C43.7, C43.70, C43.71, C43.72, C43.8, C43.9, D03, D03.0, D03.1, D03.10, D03.11, D03.12, D03.2, D03.20, D03.21, D03.22, D03.3, D03.30, D03.39, D03.4, D03.5, D03.51, D03.52, D03.59, D03.6, D03.60, D03.61, D03.62, D03.7, D03.70, D03.71, D03.72, D03.8, D03.9 | — | — | — | — | 
| 
                          PGS Performance Metric ID (PPM)  | 
                    
                        
                          PGS Sample Set ID (PSS)  | 
                    
                        Performance Source | Trait | 
                          PGS Effect Sizes (per SD change)  | 
                    
                        Classification Metrics | Other Metrics | Covariates Included in the Model | 
                          PGS Performance: Other Relevant Information  | 
                    
                    
|---|---|---|---|---|---|---|---|---|
| PPM001106 | PSS000543| European Ancestry| 11,974 individuals  | 
                        
                            PGP000118 | Fritsche LG et al. Am J Hum Genet (2020)  | 
                        
                            Reported Trait: Melanomas of skin, dx or hx | OR: 1.453 [1.37, 1.541] β: 0.374 (0.03)  | 
                        
                            AUROC: 0.6 [0.584, 0.616] | Nagelkerke's Pseudo-R²: 0.0257 Brier score: 0.0955 Odds Ratio (OR, top 1% vs. Rest): 2.39 [1.58, 3.61]  | 
                        
                            age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE172.1_GWAS-Catalog-r2019-05-03-X172.1_P_5e-08_MGI_20200608 | 
| 
                          PGS Sample Set ID (PSS)  | 
                    
                        Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS000543 | PheCode:172.1; ICD9CM:172.0, 172.1, 172.2, 172.3, 172.4, 172.5, 172.6, 172.7, 172.8, 172.9, V10.82; ICD10CM:C43, C43.0, C43.1, C43.10, C43.11, C43.12, C43.2, C43.20, C43.21, C43.22, C43.3, C43.30, C43.31, C43.39, C43.4, C43.5, C43.51, C43.52, C43.59, C43.6, C43.60, C43.61, C43.62, C43.7, C43.70, C43.71, C43.72, C43.8, C43.9, D03, D03.0, D03.1, D03.10, D03.11, D03.12, D03.2, D03.20, D03.21, D03.22, D03.3, D03.30, D03.39, D03.4, D03.5, D03.51, D03.52, D03.59, D03.6, D03.60, D03.61, D03.62, D03.7, D03.70, D03.71, D03.72, D03.8, D03.9 | — | [ 
  | 
                        
                            — | European | — | MGI | — |